Compare

Acacia Research/$ACTG

1D1W1M3M6MYTD1Y5YMAX

About Acacia Research

Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, capital base, and deep industry relationships to drive value. The company has four reportable business segments: Intellectual Property Operations, Industrial Operations, Energy Operations, and Manufacturing Operations. It derives revenue from the Intellectual Property Operations segment. Geographically, it operates in the Americas, Europe, the Middle East and Africa, China, India, and Asia-Pacific.
Ticker
$ACTG
Sector
Finance
Primary listing
NASDAQ
Employees
986

Acacia Research Metrics

BasicAdvanced
$414M
-
-$0.19
-
-

What the Analysts think about Acacia Research

Analyst ratings (Buy, Hold, Sell) for Acacia Research stock.
Analyst projections of the future price of Acacia Research stock.

Bulls say / Bears say

Acacia ended the third quarter with $346.3 million in cash, securities and loans receivable, equal to $3.55 per share, and no parent-company debt. That gives it room to fund acquisitions and operations without relying on parent-level borrowing. (Business Wire)
Benchmark Energy generated $19.5 million of revenue, its second-strongest quarter under Acacia’s ownership, and its initial Cherokee well continued to outperform expectations. A newly arranged, non-recourse financing facility will support further drilling while ring-fencing the programme’s risk from Acacia and Benchmark’s other assets. (The Motley Fool)
The operating businesses outside intellectual property generated $54.2 million of revenue in the third quarter, marking their third consecutive quarter of growth and a near-record result. They also delivered $9.1 million of adjusted EBITDA, offering a source of earnings beyond Acacia’s licensing business. (Business Wire)
Intellectual-property income remains highly episodic: third-quarter revenue fell to about $0.3 million from $7.8 million a year earlier, and the segment recorded negative adjusted EBITDA. That makes group earnings vulnerable when licensing settlements do not arrive. (The Motley Fool)
Manufacturing subsidiary Deflecto faced weaker demand and higher input costs in the third quarter. Revenue fell to $27.2 million from $30.8 million a year earlier, while adjusted EBITDA dropped to about $1.0 million from $2.6 million. (The Motley Fool)
Acacia wrote off its $30.9 million investment in MalinJ1 and Viamet after Mycovia faced liquidity problems and a delay to an FDA readout. The loss highlights the risk that investment returns can be impaired by funding and regulatory setbacks outside Acacia’s control. (The Motley Fool)
Data summarised monthly by Lightyear AI. Last updated on 6 Nov 2026.

Acacia Research Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Acacia Research Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing Acacia Research

Funds
Fund name
Fund size
$ACTG weighting
SPDR Russell 2000 US Small Cap€R2US
$5.3B0.00%
SPDR Russell 2000 US Small Cap£R2SC
$5.3B0.00%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.